BrightSpring Health Services, Inc.

BrightSpring Health Services, Inc.

BTSGNYSE / NASDAQHealthcareMid cap

$62.84-$1.18 (-1.8%)

Last close · Data as of Nov 20, 2026

Market cap
$11.3B
P/E
59.4x
EV / EBITDA
30.3x
Revenue
$12.9B
Net margin
1.5%
ROCE
6.5%

+91.8% over the last year

BrightSpring Health Services, Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
+0.7%
3M
+5.6%
6M
+7.3%
1Y
+91.8%
5Y
Short history
  • A period is left blank when the price history is shorter than the period.

52-week range

Day change -$1.18 (-1.8%) from $64 to $63 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in BTSG, bought on each weekday since 2024.

News & filings

What BrightSpring Health Services filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

ConcernOperating profit was 1.9 times interest costs.

Strengths (1)

  • Return on equity rose from -1.1% to 10.2% between fiscal 2024 and fiscal 2025.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.

Read moreShow less

BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.

Sector
Healthcare
Shares outstanding
202.8M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$11.3B
P/E
59.4x
P/B
6.0x
EV / EBITDA
30.3x
EV / Sales
1.1x
P/S
0.9x
52-week high
$72.91
52-week low
$32.76

Profitability

Operating margin
2.3%
Net margin
1.5%
EBITDA margin
3.6%
ROE
10.2%
ROCE
6.5%
ROA
3.0%
Asset turnover
2.01

Growth

Revenue
$12.9B
Revenue growth, 1Y
28.2%
Revenue CAGR, 3Y
18.7%
Net profit growth, 1Y
-1155.6%
Free cash flow
$394.7M

Solvency

Current ratio
1.57
Debt / Equity
1.44
Debt / Assets
0.42
CFO / Net profit
2.57
Cash / Market cap
0.8%

Where the revenue went

Of every $100 of FY2025 revenue, $1 was left as net income.

BrightSpring Health Services, Inc. income statement flow, FY2025
BrightSpring Health Services, Inc. income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$11.4B
RevenueGross profit$1.5B
Gross profitOperating expenses$1.2B
Gross profitOperating income$295.3M
Operating incomePretax income$137.9M
Operating incomeInterest and other expense$157.3M
Pretax incomeNet income$137.9M
Tax benefit and otherNet income$52.7M

Revenue and net profit

Revenue grew 28.2% in FY2025; net profit is the dashed line.

BrightSpring Health Services, Inc. revenue and net profit by fiscal year
BrightSpring Health Services, Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$7.7B-$53.9M
FY2023$7.7B-$154.6M
FY2024$10.1B-$18.1M
FY2025$12.9B$190.7M

Cash flows

FY2025: $490.2M from operations, $394.7M free after investment (dashed).

BrightSpring Health Services, Inc. operating and free cash flow by fiscal year
BrightSpring Health Services, Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022-$4.7M-$74.8M
FY2023$210.8M$137.3M
FY2024$23.8M-$57.1M
FY2025$490.2M$394.7M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$12.9B+28.2%1Y
EBITDA
$459.5M+53.3%1Y
Net profit
$190.7M
Cash from operations
$490.2M+1,961.8%1Y
Free cash flow
$394.7M
Revenue CAGR, 3Y
18.7%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$12.9B$459.5M$190.7M$394.7M10.2%+28.2%-1155.6%

Monthly returns

Month-by-month returns of BTSG across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$6.4B
Liabilities$4.5B
Equity$1.9B
Paid-in capital$2.0B
Retained earnings-$74.7M
Minority interest$11.3M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; BTSG highlighted.

P/E against peers

BTSG trades at 59.4x earnings against a peer median of 44.3x (a 34% premium).

Not shown (no positive earnings and no EV / Sales): Baxter International Inc., Charles River Laboratories International, Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
BrightSpring Health Services, Inc.BTSGthis companyP/E ↑ premium$11.3B59.4x6.0x10.2%30.3x
Revvity, Inc.RVTY$11.4B47.4x1.6x3.3%18.2x
Molina Healthcare, Inc.MOH$10.0B21.3x2.5x11.6%—
Baxter International Inc.BAX$10.0B-10.4x1.6x-15.6%23.2x
Krystal Biotech, Inc.KRYS$9.1B44.3x7.4x16.8%51.2x
Charles River Laboratories International, Inc.CRL$8.9B—2.8x-4.6%27.5x
Henry Schein, Inc.HSIC$8.7B21.8x2.7x12.3%12.4x
Bio-Techne CorporationTECH$8.3B113.5x4.3x3.8%39.7x
Corcept Therapeutics IncorporatedCORT$8.0B80.7x12.4x15.4%66.1x
Peer median—44.3x2.8x7.7%27.5x

Year-to-date ROI

BTSG since 1 January, against earlier years.

Historical volatility

BTSG's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

BrightSpring Health Services, Inc. operating margin by fiscal year
BrightSpring Health Services, Inc. operating margin by fiscal year
DateOperating margin
FY20223.0%
FY20230.8%
FY20241.1%
FY20252.3%
LineFY2025
Cost of revenueCost Of Revenue$11.4B
Gross profitGross Profit$1.5B
Operating expensesOperating Expense$1.2B
Selling, general and administrativeSelling General And Administration$1.2B
Total expensesTotal Expenses$12.6B
Pretax incomePretax Income$137.9M

Learn while you research

Academy chapters picked for BrightSpring Health Services, Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Valuation Multiples ExplainedThis stock trades at a P/E of 59.4, learn when high multiples are justified.6 min read
  3. 03 Growth Investing28% revenue growth is in the top tier, learn how to value growth.7 min read
  4. 04 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  5. 05 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  6. 06 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →